| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2013 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 2010 | 2012 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.120 | None | 0.500 | 0 | 0 | 2018 | 2018 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 1995 | 2013 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
lamin A/C | 0.384 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.400 | strong | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2000 | 2009 | ||||||||
|
parathyroid hormone | 0.397 | 0.846 | 1.2E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2004 | 2004 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 |